Front Cover: Design and Synthesis of Nitrogen‐Rich Triazole‐Based Mononuclear Ru(II) Arene Complexes Toward Anticancer Activities (Eur. J. Inorg. Chem. 26/2025)

The Front Cover shows a ruthenium arene-based compound, a new metal-based cancer drug that shows promise due to unique mechanisms and better targeting of cancer cells than early treatments like cisplatin. Ruthenium(II) arene scaffolds have emerged as suitable candidates due to their ligand substitution ability, selectivity, lower toxicity, and stability compared to traditional platinum-based drugs like cisplatin. More information can be found in the Research Article by S. Maji and co-workers (DOI: 10.1002/ejic.202500300).